Posted by AGORACOM-JC
at 9:55 AM on Wednesday, January 30th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
As marijuana firms flourish, Canadian exchange will hold lottery for the stock ticker POT
POT, previously the ticker for Potash Corp. of Saskatchewan before it merged with Agrium to form Nutrien, becomes available for use Feb. 1, 2019. (Richard Vogel/AP) Kristine OwramBloomberg NewsPrivacy Policy
The stock symbol POT is up for grabs on
Canadian exchanges, and demand is so high that a lottery is being held
for the first time ever to determine who gets it.
POT, previously
the ticker for Potash Corp. of Saskatchewan before it merged with Agrium
to form Nutrien, becomes available for use Friday. Not surprisingly,
the cannabis-themed symbol has attracted “significant interest,”
according to a staff notice published by the Toronto Stock Exchange.
Applications
from companies are due by 5 p.m. Tuesday in Toronto, and a random
lottery will be held Wednesday to determine the winner. TMX Group
spokeswoman Catherine Kee declined to comment on how many applications
it’s gotten, or how many of the interested companies are related to the
fast-growing cannabis sector.
POT isn’t the only marijuana-themed ticker symbol out there. Canopy Growth Corp.,
the world’s biggest cannabis company by market value, trades under the
symbol WEED in Canada and the ETFMG Alternative Harvest exchange-traded
fund uses the symbol MJ, short for Mary Jane. Other creative symbols
used by cannabis firms include TGIF, which belongs to 1933 Industries
Inc., and FSD Pharma’s HUGE.
The
POT lottery is open to companies listed on any Canadian exchange,
including the TSX, TSX Venture Exchange, Canadian Securities Exchange
and Aequitas NEO Exchange. Exchange-traded funds and issuers without an
active operating business aren’t eligible to participate.
Posted by AGORACOM-JC
at 2:23 PM on Wednesday, January 23rd, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
Canadians spent $41 million on weed in first month after legalization
Canadians bought $54 million Canadian ($41 million) of marijuana from stores in the first full month after sales were legalized, some of the clearest evidence yet of the market’s potential.
Canada’s figure for November released Wednesday follows an earlier estimate that sales were $43 million Canadian in the first two weeks following legalization on Oct. 17.
The Ottawa-based agency added cannabis to standard monthly reports on retail sales as part of wider effort to update the nation’s economic accounts.
“Retail figures will vary as new stores continue to come on line and
the marketplace continues to evolve,†the agency’s report said.
The potential for a market worth between $5.5 billion Canadian and
$10 billion Canadian a year created a boom in the value of producers
such as Canopy Growth Corp. and Aurora Cannabis Inc. Canada became the
first Group of Seven nation to legalize the drug as Prime Minister
Justin Trudeau said prohibition was a failed system that gave profits to
criminal gangs and allowed rampant youth consumption.
Tags: Marijuana, tsx-v, weed Posted in All Recent Posts, North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Canadians spent $41 million on weed in first month after legalization $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 9:11 AM on Monday, January 21st, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
——————
Higher-margin consumption options are on the way — and so are added regulations from Health Canada.
The marijuana industry blossomed before our eyes in 2018, with the cannabis movement taking steps toward legitimacy like never before.
Sean Williams – Jan 20, 2019 at 9:06AM
The marijuana industry blossomed before our eyes in 2018, with the cannabis movement taking steps toward legitimacy like never before.
In the United States, Food and Drug Administration approved its very first cannabis-derived drug, and President Trump signed the Farm Bill into law,
legalizing hemp and hemp-based cannabidiol products. But of all events,
none offered more validity to the long-term cannabis business model
than the legalization of recreational marijuana in Canada this past
October. Although this legalization will generate billions of dollars in
added annual sales, it’s the legitimacy of weed now being legal that’s
worth even more.
Image source: Getty Images.
The wait for alternative cannabis options lingers on in Canada
However, Canada’s legalization wasn’t as broad-based as you might think.
Although dried cannabis flower, sublingual sprays, and cannabis oils
were legalized, other popular forms of consumption were not. This
included edibles, cannabis-infused beverages, extracts/concentrates,
topicals, and vapes. This was likely done to expedite the approval of
the Cannabis Act through Parliament, as well as allow the industry to
get its bearings.
One of the bigger questions has been when the Canadian government
would address alternative consumption options. Since dried cannabis
flower has been commoditized in a handful of recreationally legal U.S.
states, the expectation is that Canada will follow suit in the years to
come. This puts alternative marijuana products into the spotlight, since
they’re expected to have higher price points, higher margins, and be
far less susceptible to pricing pressure, than dried flower.
New consumption options are coming, but there are caveats
Recently, Health Canada helped put some of those questions to rest by
laying out its plan of action on alternative consumption options.
According to a rough outline provided by the Canadian regulatory agency,
and detailed by the National Post,
edibles, infused beverages, topicals, and extracts should be legal by
this fall, no later than Oct. 17, 2019. That’s exactly one year after
adult-use pot became legal for sale in Canada. Of course, there are
plenty of caveats to this product expansion.
For example, the draft provided by Health Canada calls for strict
caps on the amount of tetrahydrocannabinol (THC) that these products can
contain. THC is the psychoactive cannabinoid responsible for getting a
user high. The agency suggests that no package of edibles would be
permitted more than 10 milligrams of THC, with topicals and extracts
limited to 1,000 milligrams of THC.
Image source: Getty Images.
Just as we’ve witnessed in the U.S., there would also be strict
packaging regulations on edibles to make them less appealing to
children. Packaging that resembled candy or other foods familiar with
children wouldn’t be allowed, and neither would ingredient labeling that
would attract kids, such as sweeteners. The packaging itself must also
be tamper- and child-resistant, plain, and carry the standard health
warning.
Edible, topical, and extract producers would also be barred from
making any health benefit or nutrition claims on their packaging.
Interestingly, the one item left off the list is cannabis-infused alcoholic
beverages. Although nonalcoholic infused beverages should be legal
within the next nine months, those containing alcohol will have to wait a
bit longer.
These companies are champing at the bit for the green flag to wave
With few exceptions, this draft from Health Canada was music to the
ears of cannabis producers and ancillary players. Now they’re simply
champing at the bit for these products to be legalized.
Last August, Molson Coors Brewing Co. (NYSE:TAP) announced a 57.5%-42.5% joint venture with Quebec-based HEXO that’ll
see the duo work on developing and retailing a line of cannabis-infused
beverages in Canada. Molson Coors has seen its beer market share
decline in Canada over the past decade, and is hoping that the marijuana
industry can reignite top-line growth with a line of non-alcoholic
infused beverages. With Molson Coors’ expertise in marketing new
products, and HEXO’s intricate knowledge of the cannabis industry, this
duo is eager to diversify their portfolio of products.
Tags: marijauna, tsx Posted in All Recent Posts, North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Marijuana Edibles and Infused Beverages Should Go On Sale in Canada by October $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 3:35 PM on Friday, January 18th, 2019
WHY NORTHBUD FARMS?
Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food,
beverage and science companies to provide safe standardized cannabinoid
infused raw inputs for large scale GMP manufacturing of products
Announced Creation of “1017†Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line
THE OPPORTUNITY
Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area
Posted by AGORACOM-JC
at 11:35 AM on Thursday, January 17th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
——————
Canadian cannabis industry executives are warning that product shortages in the country could take as long as three years to alleviate. Some insiders believe that cannabis production estimates are too optimistic, according to a report from Bloomberg.
Canadian cannabis industry
executives are warning that product shortages in the country could take
as long as three years to alleviate. Some insiders believe that
cannabis production estimates are too optimistic, according to a report
from Bloomberg.
Since the sale and use of recreational marijuana were legalized in October, product shortages have led some cannabis retailers to reduce hours or limit purchases. In
Alberta, regulators originally estimated that up to 250 cannabis stores
could be operating in the province by the end of this year. But product
shortages caused the province to place a moratorium on issuing licenses
in November. As a result, Alberta has only 65 cannabis retailers, with
20 of those located in the city of Calgary.
Chuck Rifici, chief executive officer of Auxly Cannabis Group Inc. in
Toronto, said that the challenges of expanding cannabis production
have made it difficult to meet the demands of the newly legal
recreational cannabis market.
“There’s a lot of execution risk, people are expanding by 10, 20 times,†Rifici said. “Personally, I think we’re at least three years out from hitting real equilibrium.â€
“Ultimately any manufacturing facility growing 20 times is likely to face delays,†he added.
Greg Engel, CEO of Organigram Holdings believes that it will take “a
couple years†for supply to catch up with demand. And Everett Knight,
the executive vice president for strategy and investments at Valens
Groworks, said it could be two to three years. He said that some
cultivators do not accurately predict production losses due to issues
such as mold.
“It’s harder to grow cannabis than most people think,†Knight said.
However, Raj Grover, the CEO of cannabis retailer High Tide, said
that supply problems are improving“on a monthly and weekly basis.â€
“Our stores in Alberta are fully stocked. They’re generating great
revenue,†Grover said. “I think Ontario’s decision to just open 25
stores is too much of an overstatement, they’re overthinking this a
little bit.â€
Government predicts ‘sufficient supply’
Tammy Jarbeau, a spokeswoman for Health Canada said in a statement in November that some product shortages could be expected.
“As with any new industry where there is considerable consumer
demand, we expect there may be periods where inventories of some
products run low or, in some cases, run out,†said Jarbeau.
“Health Canada remains confident that there is sufficient supply of
cannabis overall to meet market demand now and into the future.â€
But she added that shortages were not expected to be prolonged or widespread.
“As the overall supply chain gains experience in the Canadian
marketplace, it is expected that such localized and product-specific
shortages will become far fewer in number,†Jarbeau said.
Tags: Hemp, Marijuana Stocks Posted in North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Canadian cannabis industry execs warn weed shortage could last three years $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 3:11 PM on Thursday, January 10th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
Marijuana is going mainstream and Wall Street has started to notice. Recreational marijuana is now legal in Canada.
And even though there is still a federal ban on pot in the United States, Washington has started to loosen some regulations on other products derived from cannabis, including hemp, following the recent passage of the Farm Bill.
New York (CNN Business)Marijuana is going mainstream and Wall Street has started to notice. Recreational marijuana is now legal in Canada. And even though there is still a federal ban on pot in the United States, Washington has started to loosen some regulations on other products derived from cannabis, including hemp, following the recent passage of the Farm Bill.
Several states have also legalized recreational and medical marijuana. That’s why Vivien Azer of Cowen & Co. is extremely bullish about the prospects for cannabis companies. Â
Azer is the first analyst at a major stock research firm to start coverage of cannabis companies. She held a call with reporters on Tuesday to discuss her views on the sector. Azer covers Canada’s Canopy Growth (CGC) and Tilray (TLRY) as well as US-based cannabis packaging maker KushCo (KSHB). Â She now thinks the market for cannabis in the United States will reach $80 billion by 2030. That sales potential has already attracted the interest of several alcoholic beverage and tobacco giants seeking growth as booze and cigarette sales slump. Â
Azer expects more deals like this, particularly from the beverage makers. The rationale: Drink companies view cannabis as a product that could lessen demand for beer, wine and hard alcohol, particularly as more US states legalize marijuana. Â “Consumers say they cut back on alcohol when they mix alcohol and cannabis,” Azer said during the conference call Tuesday, adding that she would not be surprised to see Diageo (DEO), the maker of Johnnie Walker, Ketel One and Guinness, to eventually make a deal to get into the cannabis market along with other spirits companies. Â
Although Azer is predicting strong demand for legal cannabis in Canada, the United States and other parts of the world, she still thinks that many of the pot stocks got ahead of themselves leading up to the legalization of marijuana in Canada in October — and that is why many of them have fallen in the past few months. Â
She added that some dispensaries in Canada were faced with shortages of marijuana and also couldn’t handle demand for online orders. Some were forced to delay shipments. That’s led to some choppy sales in the first few weeks since legalization. Â “It comes down to fundamentals. So is it surprising to see the cannabis stocks sell off after Canada’s legalization? No. The runup was too far too fast and there were some companies that reported revenue misses,” Azer said. Â
A worker collects cuttings from a marijuana plant at the Canopy Growth Corporation facility in Smiths Falls, Ontario. Â Azer concedes that the stocks may remain volatile for a bit because they have attracted so much interest from more fickle individual investors, as opposed to big institutions like mutual funds and hedge funds. Â
But she argues that the stocks will stabilize once more long-term investors join some of the short-term traders and start buying them. That might happen sooner rather than later as Wall Street recognizes that marijuana is becoming a legitimate consumer product. Â
Piper Jaffray initiated coverage on Canopy and Tilray on Wednesday with outperform ratings. Canadian companies Aurora (ACB) and Aphria (APHA) have recently begun listing in the US, too, which means analysts may begin covering them as well. Â Source: https://www.cnn.com/2019/01/09/investing/cannabis-stocks-canopy-tilray-alcohol-tobacco-cowen/index.html
Posted by AGORACOM-JC
at 8:26 AM on Thursday, December 20th, 2018
Announced the amendment of its license application to add 500K SQ. FT. of outdoor cultivation area and provides shareholders with a corporate update on the progress of the corporation and status on its various activities.
Construction of NORTHBUD’s cultivation facility is progressing on schedule and on budget. The building is soon to be completely enclosed and ready for the next phase in construction.
TORONTO, Dec. 20, 2018 – North Bud Farms Inc. (CSE: NBUD) (“NORTHBUD” or the “Company”) announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area and provides shareholders with a corporate update on the progress of the corporation and status on its various activities.
Construction of our Cannabis Production Facility in Low, Quebec:
The
construction of NORTHBUD’s cultivation facility is progressing on
schedule and on budget. The building is soon to be completely enclosed
and ready for the next phase in construction. Please see our website www.northbud.com/blog for videos, photos and ongoing updates.
Request for Outdoor Cultivation License:
NORTHBUD
is pursuing a standard cultivation licence under The Cannabis Act after
acquiring a confirmation of readiness stage ACMPR licence application
in early 2018.
The
NORTHBUD production facility is located on a 95-acre parcel of farmland
in rural Quebec. Under the new regulations, licenced producers can
cultivate outdoors. In collaboration with Cannabis Compliance Inc.
NORTHBUD will be amending its application to include a 1000 x 500ft
outdoor cultivation area. We anticipate this outdoor production
footprint to be operational in the spring of 2020 pending the required
approvals by Health Canada. NORTHBUD expects to begin implementation of
the required infrastructure in Q2 2019 after completion of our 25k sq.
ft. indoor production facility that is currently under construction.
Implementation
of this additional low-cost production footprint will provide NORTHBUD a
unique platform to cultivate both premium quality dried flower as well
as low cost commodity grade organic biomass to be transformed into food
and pharma grade inputs. This will position NORTHBUD to capitalize on
the highest margin market segments.
As
the consumer market develops, we believe our diverse centralized
infrastructure will provide NORTHBUD a solid, low cost, high quality
cannabis supply, which will serve as the core of our products and brand
moving forward.
The
Gatineau valley has traditionally been a fertile area for outdoor
cannabis cultivation with a growing season that typically occurs between
mid June and early October. NORTHBUD will be engaging local legacy
cultivators to acquire genetics with a track record of success in this
particular climate. Our outdoor cultivation will follow international
GAP (good agricultural practices) with the drying, trimming and
packaging to be done in accordance with GMP standards inside our
state-of-the-art custom designed cultivation facility.
About North Bud Farms Inc. North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc. which was acquired in February 2018, is pursuing a licence under The Cannabis Act. North Bud Farms Inc. is constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms Inc. will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.
Neither
the Canadian Securities Exchange (the “CSEâ€) nor its Regulation
Services Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements Certain
statements included in this press release constitute forward-looking
information or statements (collectively, “forward-looking statementsâ€),
including those identified by the expressions “anticipateâ€, “believeâ€,
“planâ€, “estimateâ€, “expectâ€, “intendâ€, “mayâ€, “should†and similar
expressions to the extent they relate to the Company or its management.
The forward-looking statements are not historical facts but reflect
current expectations regarding future results or events. This press
release contains forward- looking statements. These forward-looking
statements are based on current expectations and various estimates,
factors and assumptions and involve known and unknown risks,
uncertainties and other factors. Such risks and uncertainties include,
among others, the risk factors included in North Bud Farms Inc.’s final
long form prospectus dated August 21, 2018 which is available under the
issuer’s SEDAR profile at www.sedar.com.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT: North Bud Farms Inc. Edward Miller VP, IR & Communications Office: (855) 628-3420 ext. 3 [email protected]
Tags: CSE, Hemp, Marijuana Stocks, tsx, tsx-v Posted in Featured, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca Amends Licence Application to Add 500K SQ. FT. of Outdoor Cultivation Area and Provides a Corporate Update $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 12:48 PM on Monday, December 17th, 2018
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
Two months after the legalization of recreational cannabis, is
the new legislation meeting its objectives? CTVNews.ca takes a look at
some of the Cannabis Act’s key goals.
Two months after recreational cannabis was legalized, Canada’s new
pot regime is still working out kinks in the supply chain and the
enforcement of new rules.
Before the cannabis legislation came into force, the federal
government listed its key objectives for the historic shift. Those goals
include keeping cannabis “out of the hands of children and youth,â€
curbing illegal marijuana sales, and ensuring a safe supply of quality
pot across the country.
More than 60 days after the first legal cannabis sales were made on
Oct. 17, are those objectives being met? CTVNews.ca takes a look at how
reality measures up against some of the government’s main promises.
Keep cannabis away from children
The Cannabis Act
states that only adults aged 18 or older can legally purchase, possess
and grow small amounts of weed. Provinces and territories were allowed
to impose their own age restrictions, and the majority have set 19 as
the legal age.
Quebec’s new Coalition Avenir Quebec government made good on its
election campaign promise and tabled legislation that would raise the
province’s legal cannabis consumption age to 21 – the highest in Canada.
Of course, those age restrictions don’t guarantee that younger teens
and kids won’t be getting their hands on pot. It remains to be seen
whether legalization will actually reduce cannabis consumption among
minors.
Reduce number of Canadians with criminal records
One of the main pillars of the Cannabis Act is reducing the burden on
the Canadian justice system by eliminating criminal charges for simple
pot possession. But what about those who were charged or convicted of
the crime before Oct. 17, 2018?
In October, the federal government announced its intention to issue
pardons to Canadians who have criminal records for possession of 30
grams of cannabis or less.
The legislation “to make things fairerâ€
was expected to be tabled before the end of 2018, but that did not
happen before MPs wrapped things up in Ottawa for the holiday break.
When it eventually becomes law, those eligible for pardons will be able
to apply as soon as the law is in effect, with no waiting period or
application fees.
The Liberal government, however, has been criticized for not opting
to expunge the criminal records of Canadians convicted of simple
possession. An expungement would remove any record of a criminal
conviction, while a pardon seals the record but does not erase it.
Safe supply of cannabis
The federal government pledged to “establish and enforce a strict
system of production, distribution and sales†of cannabis, with a focus
on regulation of quality and safety.
But some Canadians have reported receiving mouldy cannabis.
One cannabis manufacturer, RedeCan, recalled its B.E.C. strain in November after receiving reports of mould in some products sold in Ontario and British Columbia.
Under federal regulations, cannabis producers have to keep a sample of every batch they send to market.
Eliminate illicit pot sales
This is another long-term objective of the Cannabis Act, but numerous
hiccups in the legal cannabis supply chain have done little to curb
distribution of illegal weed.
Despite numerous warnings to illegal cannabis stores – and police
raids in several cities across the country – some illicit dispensaries say they’ve been busier than ever since Oct. 17.
Some consumers told The Canadian Press they continued to get their
weed from illegal dispensaries or elsewhere because of delivery delays
like the ones that plagued the Ontario Cannabis Store (OCS) in the first
month of legalization.
The OCS attributed delays to high demand for cannabis products, but
the nationwide rotating strikes by Canada Post workers were also blamed
for slow deliveries.
The online OCS is currently the only legal outlet for recreational
cannabis in Ontario, with brick-and-mortar stores expected in 2019.
In the first few weeks of business, the office of the
Ontarioombudsman received more than 1,000 complaints about the OCS,
related to delivery delays, poor customer service and issues with
billing.
By the third week of November, the provincial government said the OCS had eliminated its backlog and deliveries were “back on track.â€
British Columbia, Alberta, Manitoba, Saskatchewan, Quebec, Nova
Scotia and New Brunswick also reported varying degrees of cannabis
shortages.
New Brunswick was forced to temporarily close more than half its stores in early November, and the Quebec Cannabis Corporation had to reduce its store opening hours due to shortages.
Access to medical cannabis
One of the government’s principal objectives in legalizing
recreational pot was to provide “access to quality-controlled cannabis
for medical purposes.â€
But medical cannabis users have complained that, since Oct. 17,
they’ve experienced persistent product shortages and shipment delays.
Users of medical cannabis can only buy products from specific
licensed producers if they want their health insurance to cover the
cost. When their preferred strain or product is not available, they
either have to go without, or pay out of pocket for products from a
recreational pot retailer.
Health Canada admitted last month
that there have been localized shortages of medical cannabis since
legalization, and said they are expected to continue for months.
Protecting public health and safety
The federal government has vowed to strengthen laws aimed at
punishing “more serious cannabis offences,†including selling and
distributing pot to children and youth, and driving under the influence
of cannabis.
Legislation known as Bill C-46
sets prohibited blood drug concentrations of THC, the main psychoactive
compound of cannabis, for drivers. It also outlines penalties for drug
offences, which range from fines to imprisonment, depending on the
severity and number of offences committed.
As a result of Bill C-46, police can now demand a sample of saliva
for roadside drug screening. However, the only device approved for
roadside drug testing in Canada has been met with criticism, with some
police forces even saying they will not be using it at all.
Critics say the Drager DrugTest 5000
doesn’t work in sub-zero temperatures, is too bulky for roadside tests
and takes too long to produce a sample. But the federal government has
defended the device, saying its approval was based on scientific
recommendations of the Drugs and Driving Committee.
Bill C-46 also amended Canada’s drunk-driving laws to allow police officers to conduct mandatory roadside alcohol breath tests without requiring a suspicion that the driver had been drinking.
With files from CTVNews.ca’s Rachel Aiello and The Canadian Press
Tags: Marijuana, stocks, tsx, tsx-v, weed Posted in North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Cannabis report card: How’s the legal pot regime working for Canadians? $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 11:10 AM on Thursday, December 13th, 2018
NBUD:CSE
WHY NORTHBUD FARMS?
Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening in 2019 As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
Announced Creation of “1017†Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line
 NORTHBUD Construction Update, Everything is on schedule!
FULL DISCLOSURE: North Bud Farms is an advertising client of AGORA Internet Relations Corp.
Tags: Hemp, Marijuana Stocks Posted in All Recent Posts, North Bud Farms Inc | Comments Off on CLIENT FEATURE: North Bud Farms $NBUD.ca sustainable low cost, high quality cannabinoid production and procurement $ACB $WEED.ca $HIP.ca
